Techcyte, the developer of Fusion, the unified anatomic and clinical pathology AI platform, today announced the integration of two Aira Matrix AI algorithms into Fusion AP: AIRAProstate, an automated ...

Good afternoon, everyone, and thank you for joining us today to discuss Kyntra Bio, Inc.’s first quarter 2026 financial and business results. I am Gaia Vasiliver-Shamis from LifeSci Advisors. Joining ...

Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.

The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.

ABEO READ THE FULL ABEO RESEARCH REPORT Business Update Three Patients Treated in 1Q26, Seven Patients In-queue Abeona ...

CLEVELAND, May 13, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2026, highlighting commercial momentum for ZEVASKYN.

Designation recognizes the product’s potential to address a critical unmet need in bladder cancer prognosis PALO ALTO, Calif.--(BUSINESS WIRE)--Valar Labs, an AI precision oncology company developing ...

EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy-based therapies, today announced that it will ...

TLX597-Tx is a PSMA1-targeting small molecule radioligand therapy (RLT) candidate, designed to improve quality-of-life and efficacy in earlier-stage prostate cancer.OPTIMAL-PSMA2 initial dosimetry ...

The 51-year-old was hired to join the New England Patriots' staff in January 2025 after spending six seasons with Mike Vrabel ...

For those with inflammatory bowel diseases like ulcerative colitis (UC), which includes symptoms like diarrhea, rectal ...